Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.

Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.

Zilbauer M, Jenke A, Wenzel G, Goedde D, Postberg J, Phillips AD, Lucas M, Noble-Jamieson G, Torrente F, Salvestrini C, Heuschkel R, Wirth S.

Inflamm Bowel Dis. 2011 Oct;17(10):2076-86. doi: 10.1002/ibd.21577. Epub 2010 Dec 16.

PMID:
21910169
2.

Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.

Perminow G, Beisner J, Koslowski M, Lyckander LG, Stange E, Vatn MH, Wehkamp J.

Am J Gastroenterol. 2010 Feb;105(2):452-9. doi: 10.1038/ajg.2009.643. Epub 2009 Nov 10.

PMID:
19904243
3.

Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL.

Gut. 2008 Jul;57(7):903-10. doi: 10.1136/gut.2007.142588. Epub 2008 Feb 27.

PMID:
18305068
4.

Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.

Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E, Bok L, Peppelenbosch MP, Faber KN, Kleibeuker JH, Dijkstra G.

Inflamm Bowel Dis. 2008 Dec;14(12):1615-22. doi: 10.1002/ibd.20610.

PMID:
18668679
5.

Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.

Nielsen OH, Rüdiger N, Gaustadnes M, Horn T.

Scand J Gastroenterol. 1997 Oct;32(10):1028-34.

PMID:
9361176
6.

Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.

Verdier J, Begue B, Cerf-Bensussan N, Ruemmele FM.

Inflamm Bowel Dis. 2012 Jul;18(7):1260-6. doi: 10.1002/ibd.21905. Epub 2011 Oct 12.

PMID:
21994045
7.

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF.

Eur J Gastroenterol Hepatol. 2002 Jul;14(7):745-52.

PMID:
12169983
8.

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.

Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A, Göke B, Ochsenkühn T, Müller-Myhsok B, Lohse P, Brand S.

Inflamm Bowel Dis. 2008 Apr;14(4):437-45.

PMID:
18088064
9.

Defensins and inflammation: the role of defensins in inflammatory bowel disease.

Ramasundara M, Leach ST, Lemberg DA, Day AS.

J Gastroenterol Hepatol. 2009 Feb;24(2):202-8. doi: 10.1111/j.1440-1746.2008.05772.x. Review.

PMID:
19215333
10.

Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia.

Frye M, Bargon J, Lembcke B, Wagner TO, Gropp R.

Eur J Clin Invest. 2000 Aug;30(8):695-701.

PMID:
10964161
11.

Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.

Katsuta T, Lim C, Shimoda K, Shibuta K, Mitra P, Banner BF, Mori M, Barnard GF.

Am J Gastroenterol. 2000 Nov;95(11):3157-64.

PMID:
11095335
12.

New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients.

Pierdomenico M, Stronati L, Costanzo M, Vitali R, Di Nardo G, Nuti F, Oliva S, Cucchiara S, Negroni A.

J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):271-9. doi: 10.1097/MPG.0b013e3182034d08.

PMID:
21336161
13.

Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.

Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, Bevins CL.

FEBS Lett. 2006 Oct 2;580(22):5344-50. Epub 2006 Sep 12.

14.

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.

Matsuda R, Koide T, Tokoro C, Yamamoto T, Godai T, Morohashi T, Fujita Y, Takahashi D, Kawana I, Suzuki S, Umemura S.

Inflamm Bowel Dis. 2009 Mar;15(3):328-34. doi: 10.1002/ibd.20759.

PMID:
18942752
15.

Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.

Negroni A, Stronati L, Pierdomenico M, Tirindelli D, Di Nardo G, Mancini V, Maiella G, Cucchiara S.

Inflamm Bowel Dis. 2009 Aug;15(8):1145-54. doi: 10.1002/ibd.20907.

PMID:
19266573
16.

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

Schauber J, Rieger D, Weiler F, Wehkamp J, Eck M, Fellermann K, Scheppach W, Gallo RL, Stange EF.

Eur J Gastroenterol Hepatol. 2006 Jun;18(6):615-21.

PMID:
16702850
17.

Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.

Stronati L, Negroni A, Pierdomenico M, D'Ottavio C, Tirindelli D, Di Nardo G, Oliva S, Viola F, Cucchiara S.

Dig Liver Dis. 2010 Dec;42(12):848-53. doi: 10.1016/j.dld.2010.04.003. Epub 2010 May 7.

PMID:
20452301
18.

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.

Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schröder JM, Bevins CL, Fellermann K, Stange EF.

Gut. 2004 Nov;53(11):1658-64.

19.

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.

Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, Minelli F, Di Nardo G, Nuti F, Pierdomenico M, Cucchiara S, Stronati L.

Inflamm Bowel Dis. 2012 May;18(5):913-24. doi: 10.1002/ibd.21899. Epub 2011 Oct 12.

PMID:
21994005
20.

Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.

Rahier JF, De Beauce S, Dubuquoy L, Erdual E, Colombel JF, Jouret-Mourin A, Geboes K, Desreumaux P.

Aliment Pharmacol Ther. 2011 Sep;34(5):533-43. doi: 10.1111/j.1365-2036.2011.04759.x. Epub 2011 Jul 7.

Supplemental Content

Support Center